Moderna stock surges as melanoma vaccine trial shows "landmark moment"

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.

• Aug 19

Maryland Begins Offering FDA-Authorized Pills To Treat COVID-19

Maryland is distributing 4,500 courses of FDA-authorized prescription pills intended to help high-risk COVID-19 patients ward off serious illness, the state Department of Health announced Friday.

• Dec 31, 2021

New Pill Could Reduce Risk of Hospitalization, Death From COVID-19, But Experts Say Vaccines Remain Best Tool

Their study shows the pill has cut the risk of hospitalization or death from COVID-19 in at-risk patients by 50%. Still, doctors continue to stress vaccines remain the number one tool in the fight against COVID-19.

• Oct 4, 2021

'Every One Of Those Deaths Is Unnecessary,' Expert Says Of Rising COVID-19 US Death Toll As Tens Of Millions Remain Unvaccinated

• Oct 3, 2021

Merck Will Begin To Produce Johnson & Johnson One-Shot COVID-19 Vaccine, Officials Say

Drugmaker Merck & Co. will help produce rival Johnson & Johnson's newly approved coronavirus vaccine in an effort to expand supply more quickly, a Biden administration official confirmed Tuesday.

• Mar 2, 2021

MedImmune, Merck Share Md. Manufacturing Space

MedImmune says it will share its manufacturing space in Frederick with pharmaceutical giant Merck & Co.

• Sep 21, 2011